Recent

% | $
Quotes you view appear here for quick access.

Forest Laboratories Inc. Message Board

mirror_world_man 17 posts  |  Last Activity: May 20, 2015 1:54 PM Member since: Mar 23, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • mirror_world_man by mirror_world_man May 20, 2015 1:54 PM Flag

    Talking SVC signicance

    Sentiment: Strong Buy

  • mirror_world_man by mirror_world_man May 14, 2015 11:35 PM Flag

    Looks like Bloom et al wants to increase stock available to the BOD by over 3MM.

  • Again, of course it has nothing to do with any great earnings, super cash in the bank, no debt, or new favorable trial designs announcements. CYTK is a stable stock for at least another quarter or two. Then the rodeos gets beyond these preliminary maneurvering and the options really take off. The interim analysis for OM or Tira will not be released early, (unless some statistcally significant benefit or disbenefit is seen in a short time frame). So sit back, hold the stock or buy on the dips. Sell a chunk on the peaks, or not. The dips are manufactured, relatively easy to do when there is not a lot of stock in the float and everyone holds. If you are nervous, buy some puts...

    Sentiment: Strong Buy

  • mirror_world_man mirror_world_man May 10, 2015 9:51 PM Flag

    check all your floats from all the stocks and i would be surprised if there are many small numbers vs OS. The only acid test I use in looking at true trading shares is how volatile the SP moves on low or average volume days. I ignore floats as a rule IMHO

    Sentiment: Strong Buy

  • Low short interest. Not much left over for us retail. The vertically challenged brought it down $2 hoping to scoop up earnings heebeegeebees and stop losses to cover. I hope you all bought and/or held. retail can make a difference here. All the best to all and expect more rodeos in the next 4 months. It's a stable situation over the quarter and don't let sudden price drops scare you.

    Sentiment: Strong Buy

  • Reply to

    Hey Standardmonster...

    by sawgrassguy May 5, 2015 3:25 PM
    mirror_world_man mirror_world_man May 5, 2015 11:36 PM Flag

    It's interesting the shorts started so early before earnings. I have picked up a few thousand and will grab more in the days post CC. They will dump the stock regardless of how good the quarterlies are anyways, so we are guaranteed more bargains and averaging down. It's just a matter of how much buying pressure retail can exert. The recent divestment and focus upon manocept platform suggest lymphoseek is where the money is, so they must have some good feedback on potential. I have seen stock over 110% shorted (via warrants) before jumping. GLTA

    Sentiment: Strong Buy

  • only the bids...

  • omecamtiv mecarbil
    During the quarter, patient enrollment completed in COSMIC-HF (Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure). COSMIC-HF is a Phase II, double-blind, randomized, placebo-controlled, multicenter clinical trial designed to assess the pharmacokinetics and tolerability of omecamtiv mecarbil dosed orally in patients with heart failure and left ventricular systolic dysfunction as well as its effects on echocardiographic measures of cardiac function. Over 275 patients have completed the 20-week duration of dosing in the expansion phase of COSMIC-HF. This trial is being conducted by Amgen in collaboration with Cytokinetics.

    Sentiment: Strong Buy

  • Reply to

    4 buy ratings, 1 hold rating

    by mirror_world_man May 2, 2015 1:21 PM
    mirror_world_man mirror_world_man May 3, 2015 5:35 PM Flag

    There is $117,000,000 cash, divided by 38,000,000 outstanding shares, thats about $3/share if they decided to give it all to us. Nice value

    Sentiment: Strong Buy

  • mirror_world_man by mirror_world_man May 2, 2015 1:21 PM Flag

    Consensus Ratings for Cytokinetics (NASDAQ:CYTK) (?)
    Ratings Breakdown: 1 Hold Rating(s), 5 Buy Rating(s)
    Consensus Rating: Buy (Score: 2.83)
    Consensus Price Target: $10.73 (89.97% upside)

    Sentiment: Strong Buy

  • Reply to

    Call was not that bad

    by mario_themario May 1, 2015 2:30 PM
    mirror_world_man mirror_world_man May 1, 2015 3:48 PM Flag

    stock started to fall prior to any CC. As is the case for many BT's and BP's prior to earnings, so data in the quarterly has nothing to do do with it..The selling is manufactured, and without cause. I picked up another block and still have bids as low #$%$20's. Better in my hands than the shorts...GLTA

    Sentiment: Strong Buy

  • Reply to

    Amgen and OM

    by aecooter33 Apr 22, 2015 12:19 AM
    mirror_world_man mirror_world_man May 1, 2015 11:52 AM Flag

    Sorry, I should of said Phase III trial for OM. The COSMIC HF is looking more at pharmacokinetics and tolerability, with efficacy not a primary endpoint. IMHO Also, I am nibbling at these prices as it drops and tripled my exposure in CYTK. Those of us that have been here a while have seen these dips as a regular occurrance and a good opportunity to earn some extra cash and keep things interesting. At the very least, hold all shares until Tira is done with Phase 3. Dont let the price manipulation pull you down, buy if you can, hold if you cant.

    Sentiment: Strong Buy

  • Reply to

    Amgen and OM

    by aecooter33 Apr 22, 2015 12:19 AM
    mirror_world_man mirror_world_man May 1, 2015 1:38 AM Flag

    if the COSMIC trial is not halted early for statistically significant disbeneifit then hold your shares for a little while post trial completion. If top line positive results are not announced early prior to major medical meeting then sell shares before the meeting. This is because If the results are overwhelmingly positive, there is a moral obligation to make them public as soon as possible. The time frame post trial termination and before headline announcement is the window of opportunity, the longer it is, the less likely the primary endpoint is super.

    Sentiment: Strong Buy

  • mirror_world_man by mirror_world_man Apr 29, 2015 7:58 PM Flag

    I love these pre earnings volatility in the days before. Like the dives are suppose to indicate that anyone knows anything. I know it was nice time to place low bids. What happens tomorrow is irrelevant in the long term. Worries and surprise are short lived. We will see an update on trial implementation and partnerships. Explanation of revenue sources and revised timelines. We are still hovering around $1.15 a share pre-reverse split and in a much stronger position with more information.

    Sentiment: Strong Buy

  • Reply to

    FDA agrees on SVC primary endpoint

    by aecooter33 Mar 25, 2015 12:14 PM
    mirror_world_man mirror_world_man Mar 25, 2015 3:39 PM Flag

    One important lesson from the B-ALS is to keep energy levels up, the trial population remains well fed during the Phase 3. No empty calories...

    Sentiment: Strong Buy

  • Reply to

    The news release

    by warrenw6630 Mar 25, 2015 10:02 AM
    mirror_world_man mirror_world_man Mar 25, 2015 1:31 PM Flag

    The knee jerk is not unusual in heavily shorted BT's of which CYTK is not, so it is a bit odd. I guessed the move to PIII was giving some BB's the tizzies of an offering to pay for the trials, or some people want in at a lower price. The results look ok after only a single dose. IMHO the bottom line is that those that dumped did so on automatic pilot, or have a longer range plan. I nibbled a bit on the way down, there is no harm as far as I can see.

    Sentiment: Strong Buy

  • mirror_world_man by mirror_world_man Mar 21, 2015 5:22 PM Flag

    Stocks that warrant a look in the health care sector include Cytokinetics, Inc. CYTK, Acorda Therapeutics, Inc. ACOR and Affymetrix Inc. AFFX. All of these carry a Zacks Rank #1 (Strong Buy). 2013 they said the same thing and CYTK popped to almost double a little later.

    Sentiment: Strong Buy